These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression. Song H; Li D; Wang X; Fang E; Yang F; Hu A; Wang J; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q J Hematol Oncol; 2020 Mar; 13(1):24. PubMed ID: 32216806 [TBL] [Abstract][Full Text] [Related]
25. The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35. Liu PY; Tee AE; Milazzo G; Hannan KM; Maag J; Mondal S; Atmadibrata B; Bartonicek N; Peng H; Ho N; Mayoh C; Ciaccio R; Sun Y; Henderson MJ; Gao J; Everaert C; Hulme AJ; Wong M; Lan Q; Cheung BB; Shi L; Wang JY; Simon T; Fischer M; Zhang XD; Marshall GM; Norris MD; Haber M; Vandesompele J; Li J; Mestdagh P; Hannan RD; Dinger ME; Perini G; Liu T Nat Commun; 2019 Nov; 10(1):5026. PubMed ID: 31690716 [TBL] [Abstract][Full Text] [Related]
26. Erratum: MiR-4295 promotes cell growth in bladder cancer by targeting BTG1. Nan YH; Wang J; Wang Y; Sun PH; Han YP; Fan L; Wang KC; Shen FJ; Wang WH Am J Transl Res; 2017; 9(4):1960. PubMed ID: 28469801 [TBL] [Abstract][Full Text] [Related]
27. Erratum: "miR-182 promotes cell proliferation and invasion by inhibiting APC in melanoma". Liu X; Li H; Wu G; Cui S Int J Clin Exp Pathol; 2022; 15(3):152-154. PubMed ID: 35414840 [TBL] [Abstract][Full Text] [Related]
28. Erratum: Interleukin-17 promotes the development of ovarian cancer through upregulation of MTA1 expression. Guo N; Zhang J Am J Cancer Res; 2023; 13(2):709-710. PubMed ID: 36895973 [TBL] [Abstract][Full Text] [Related]
29. YY1 transcription factor induces proliferation and aerobic glycolysis of neuroblastoma cells via LDHA regulation. Wang Q; Fan W; Liang B; Hou B; Jiang Z; Li C Exp Ther Med; 2023 Jan; 25(1):37. PubMed ID: 36569438 [TBL] [Abstract][Full Text] [Related]
36. Erratum. Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU Clin Mol Hepatol; 2015 Mar; 21(1):104. PubMed ID: 25834809 [TBL] [Abstract][Full Text] [Related]
37. Erratum: Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum]. Int J Nanomedicine; 2018; 13():4507. PubMed ID: 30122923 [TBL] [Abstract][Full Text] [Related]
39. Erratum: SNHG8 is identified as a key regulator in non-small-cell lung cancer progression sponging to miR-542-3p by targeting CCND1/CDK6 [Erratum]. Onco Targets Ther; 2018; 11():8013. PubMed ID: 30519042 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression. Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]